RETN and colorectal carcinoma: When we restricted the main analysis to cases and matched controls who were diagnosed within the first 2 years of follow-up, we found that participants in the highest as compared to the lowest quartile of resistin concentrations had a 1.97-fold risk of CRC (95% CI: 1.06–3.64; p-trend < 0.001); RR per doubling of resistin, 1.44; 95% CI: 0.97–2.12; Supplementary Table S2.